Document Detail


Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma.
MedLine Citation:
PMID:  9598857     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two cases of acute tumor lysis syndrome occurring in patients with hepatocellular carcinoma are reported. Both patients were treated with transcatheter chemoembolization. Tumor lysis syndrome was not anticipated in the first case and was diagnosed late. However, the second patient's syndrome was detected early and treated appropriately. Subtle changes in electrolytes may be missed because of aggressive hydration that many of these patients receive because of cisplatin therapy. I propose that all patients with large hepatoma, particularly those with a short history, be monitored closely for acute tumor lysis syndrome.
Authors:
I A Burney
Related Documents :
10668117 - Recurrent tolosa-hunt syndrome: a report of ten new cases.
21622697 - The loss of vacuolar protein sorting 11 (vps11) causes retinal pathogenesis in a verteb...
20527277 - Steven johnson syndrome in a patient with cushing's disease.
20810047 - Clinicopathological features of transient myeloproliferative syndrome and congenital le...
14761147 - Familial urticaria pigmentosa associated with thrombocytosis as the initial symptom of ...
3672677 - Urologic manifestations of aids.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Southern medical journal     Volume:  91     ISSN:  0038-4348     ISO Abbreviation:  South. Med. J.     Publication Date:  1998 May 
Date Detail:
Created Date:  1998-05-28     Completed Date:  1998-05-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0404522     Medline TA:  South Med J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  467-70     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antineoplastic Agents / administration & dosage,  adverse effects
Carcinoma, Hepatocellular / therapy*
Chemoembolization, Therapeutic*
Cisplatin / administration & dosage,  adverse effects
Fatal Outcome
Humans
Liver Neoplasms / therapy*
Male
Middle Aged
Tumor Lysis Syndrome / diagnosis*
Water-Electrolyte Balance / drug effects
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 15663-27-1/Cisplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chromobacterium violaceum infection.
Next Document:  Hypersensitivity reaction to azathioprine.